215 related articles for article (PubMed ID: 1522889)
1. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
Simons M; Edelman ER; DeKeyser JL; Langer R; Rosenberg RD
Nature; 1992 Sep; 359(6390):67-70. PubMed ID: 1522889
[TBL] [Abstract][Full Text] [Related]
2. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA.
Jarvis TC; Alby LJ; Beaudry AA; Wincott FE; Beigelman L; McSwiggen JA; Usman N; Stinchcomb DT
RNA; 1996 May; 2(5):419-28. PubMed ID: 8665409
[TBL] [Abstract][Full Text] [Related]
5. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle cell proliferation: basic investigations and new therapeutic approaches.
Rosenberg RD
Thromb Haemost; 1993 Jul; 70(1):10-6. PubMed ID: 8236084
[TBL] [Abstract][Full Text] [Related]
7. [Effect of antisense oligonucleotides on myo-intimal hyperplasia in a model of abdominal aortic injury in the rat].
Chemla E; Julia P; Nierat J; Eudes D; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1995 Mar; 88(3):381-9. PubMed ID: 7487292
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
[TBL] [Abstract][Full Text] [Related]
9. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
11. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of antisense oligonucleotides delivered locally via hydrogel catheter on myointimal hyperplasia of rat carotid artery after nitrogen drying].
Xi Y; Wang L; Zhu G
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):109-11. PubMed ID: 8758441
[TBL] [Abstract][Full Text] [Related]
13. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
16. [Suppression of vascular smooth muscle cell proliferation by an antisense oligonucleotide against PDGF receptor].
Sugiki H
Hokkaido Igaku Zasshi; 1995 May; 70(3):485-95. PubMed ID: 7590599
[TBL] [Abstract][Full Text] [Related]
17. Antisense Egr-1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injury.
Fahmy RG; Khachigian LM
J Cell Biochem; 2002; 84(3):575-82. PubMed ID: 11813262
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
del Rio M; Sunkel C; Larcher F; Ortega MP
Br J Pharmacol; 1997 Apr; 120(7):1360-6. PubMed ID: 9105713
[TBL] [Abstract][Full Text] [Related]
19. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
Venturelli D; Mariano MT; Szczylik C; Valtieri M; Lange B; Crist W; Link M; Calabretta B
Cancer Res; 1990 Nov; 50(22):7371-5. PubMed ID: 2224864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
